Holen Sie sich die Stockscreener-App
54.81
10.09%
4.85
Celcuity Inc Aktie (CELC) Neueste Nachrichten
Celcuity Inc. stock momentum explainedJuly 2025 Sector Moves & Growth Focused Stock Reports - Newser
Volume spikes in Celcuity Inc. stock – what they meanJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - Newser
What to do if you’re stuck in Celcuity Inc.Earnings Miss & Community Driven Trade Alerts - Newser
Celcuity Shares Soar After FDA Accepts Gedatolisib NDA for Review - MSN
Is Celcuity Inc. showing signs of accumulationEarnings Overview Report & Long Hold Capital Preservation Plans - Newser
Celcuity stock jumps after FDA accepts gedatolisib NDA for review - Investing.com
Sector Update: Health Care Stocks Edge Higher Premarket Thursday - MarketScreener
Using data filters to optimize entry into Celcuity Inc.July 2025 Selloffs & Smart Swing Trading Techniques - Newser
Will Celcuity Inc. bounce back from current support2025 Year in Review & Fast Gain Swing Trade Alerts - Newser
How to build a dashboard for Celcuity Inc. stockTreasury Yields & AI Powered Market Entry Ideas - Newser
Smart tools for monitoring Celcuity Inc.’s price actionJuly 2025 Catalysts & Weekly Chart Analysis and Guides - Newser
What technical models suggest about Celcuity Inc.’s comebackMarket Trend Review & Reliable Entry Point Alerts - Newser
What recovery options are there for Celcuity Inc.Insider Selling & Weekly High Return Stock Opportunities - Newser
Celcuity’s Gedatolisib Gains Momentum with FDA’s RTOR Program and Promising Phase 3 Trial Results - TipRanks
Celcuity to initiate gedatolisib NDA submission - TipRanks
Is this a good reentry point in Celcuity Inc.Long Setup & Accurate Entry/Exit Alerts - Newser
Celcuity Inc. shares rise 13.07% after-hours after FDA accepted NDA review for gedatolisib in HR+/HER2- advanced breast cancer. - AInvest
Celcuity to Initiate NDA Submission of Gedatolisib in - GlobeNewswire
Celcuity Gets US FDA Acceptance for NDA Review of Breast Cancer Drug Candidate - MarketScreener
Published on: 2025-08-27 15:43:45 - Newser
How to forecast Celcuity Inc. trends using time seriesBuy Signal & High Accuracy Buy Signal Tips - Newser
Will Celcuity Inc. continue its uptrendWeekly Stock Analysis & Daily Price Action Insights - Newser
Top chart patterns to watch in Celcuity Inc.Weekly Volume Report & Real-Time Volume Analysis Alerts - Newser
How hedge fund analytics apply to Celcuity Inc. stockQuarterly Growth Report & Free Safe Capital Growth Stock Tips - Newser
Is it time to cut losses on Celcuity Inc.Portfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
What momentum shifts mean for Celcuity Inc.Portfolio Value Summary & Low Risk Entry Point Tips - Newser
Does Celcuity Inc. show high probability of reboundTreasury Yields & AI Powered Trade Plan Recommendations - Newser
How to build a custom watchlist for Celcuity Inc.Trend Reversal & Low Risk Entry Point Guides - Newser
Heatmap analysis for Celcuity Inc. and competitors2025 Geopolitical Influence & Stepwise Swing Trade Plans - Newser
Is it time to cut losses on Celcuity IncJuly 2025 Outlook & Short-Term High Return Strategies - Newser
Understanding Celcuity Inc.’s price movementEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
Celcuity price target raised to $66 from $50 at H.C. Wainwright - MSN
Applying big data sentiment scoring on Celcuity Inc.Portfolio Return Summary & Safe Entry Zone Identification - Newser
Celcuity Inc. Recovers — But Is It Sustainable2025 Year in Review & Growth-Oriented Investment Plans - newsyoung.net
How to recover losses in Celcuity Inc. stockWeekly Volume Report & Verified Stock Trade Ideas - Newser
1.39%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):